Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin effects on vascular structure in Metabolic Syndrome
NCT00105066Phase 2Completed
- Sponsor
- National Institute on Aging
- Start
- Jan 2004
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in metabolic syndrome, sponsored by National Institute on Aging. Started Jan 2004; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT00105066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00105066.